908 Devices (MASS) EBITDA Margin Growth (1y) (2021 - 2026)
908 Devices (MASS) EBITDA Margin Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.89 Bn | 173.59 Bn | 6.27 Bn | -430.00 |
| 2 | Stryker | 127.82 Bn | 124.94 Bn | 3.81 Bn | 128.00 |
| 3 | Medtronic | 107.49 Bn | 98.27 Bn | 6.41 Bn | 301.00 |
| 4 | Boston Scientific | 67.24 Bn | 65.78 Bn | 3.61 Bn | 141.00 |
| 5 | Edwards Lifesciences | 48.02 Bn | 44.34 Bn | 1.29 Bn | 102.00 |
| 6 | Dexcom | 28.25 Bn | 27.14 Bn | 750.30 Mn | 851.00 |
| 7 | GE HealthCare Technologies | 28.17 Bn | 25.89 Bn | 1.98 Bn | -313.00 |
| 8 | Smith & Nephew | 26.72 Bn | 26.14 Bn | - | - |
| 9 | Koninklijke Philips | 25.31 Bn | 22.19 Bn | 2.07 Bn | 241.00 |
| 10 | 908 Devices | 268.41 Mn | 156.67 Mn | 6.88 Mn | -266.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -266.00 |
| Dec 31, 2025 | 13,457.00 |
| Sep 30, 2025 | 5,214.00 |
| Jun 30, 2025 | -4,181.00 |
| Mar 31, 2025 | 892.00 |
| Dec 31, 2024 | -4,909.00 |
| Sep 30, 2024 | -10,513.00 |
| Jun 30, 2024 | 1,595.00 |
| Mar 31, 2024 | 3,466.00 |
| Dec 31, 2023 | 2,111.00 |
| Sep 30, 2023 | -1,829.00 |
| Jun 30, 2023 | -1,509.00 |
| Mar 31, 2023 | -2,258.00 |
| Dec 31, 2022 | -6,652.00 |
| Sep 30, 2022 | -323.00 |
| Jun 30, 2022 | 1,471.00 |
| Mar 31, 2022 | -981.00 |
| Dec 31, 2021 | 4,570.00 |
| Sep 30, 2021 | -2,068.00 |
| Jun 30, 2021 | -10,919.00 |